NCT03834454 is a NA clinical trial of Bupivacaine in Cesarean Section, sponsored by Indonesia University.

Who is sponsoring NCT03834454?

NCT03834454 is sponsored by Indonesia University.

What drugs are being tested in NCT03834454?

Interventions in NCT03834454: Bupivacaine, Bupivacaine.

What condition does NCT03834454 study?

NCT03834454 studies Cesarean Section, Hypotension Drug-Induced, Spinal Anesthesia, Postoperative Complications.

Is NCT03834454 still recruiting?

NCT03834454 is currently completed. Last updated 11 February 2019.

Last reviewed 2019-02-11 · How we verify

NCT03834454

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Bupivacaine 5 mg vs 7.5 mg for Spinal Anesthesia in Cesarean Delivery in Indonesian Population

Completed NA Last updated 11 February 2019

What this trial tests

NA trial testing Bupivacaine in Cesarean Section in 112 participants. Completed in 31 December 2013.

Timeline

1 October 2013

Primary endpoint
31 December 2013

31 December 2013

Quick facts

Lead sponsor	Indonesia University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	supportive care
Enrollment	112
Start date	1 October 2013
Primary completion	31 December 2013
Estimated completion	31 December 2013
Sites	1 location across Indonesia

Drugs / interventions tested

Bupivacaine (BUPIVACAINE) — full drug profile →
Bupivacaine (BUPIVACAINE) — full drug profile →

Conditions studied

Cesarean Section — all drugs for Cesarean Section →
Hypotension Drug-Induced — all drugs for Hypotension Drug-Induced →
Spinal Anesthesia — all drugs for Spinal Anesthesia →
Postoperative Complications — all drugs for Postoperative Complications →

Sponsor

Indonesia University

Who can join

Adults 18 to 40, female only, with Cesarean Section or Hypotension Drug-Induced. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to evaluate the efficacy of hyperbaric 5 mg bupivacaine + fentanyl 25 mcg versus hyperbaric 7.5 mg bupivacaine + fentanyl 25 mcg to lower incidence of hypotension

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

How Low Can We Go? A Double-Blinded Randomized Controlled Trial to Compare Bupivacaine 5 mg and Bupivacaine 7.5 mg for Spinal Anesthesia in Cesarean Delivery in Indonesian Population.
Chandra S, Nugroho AM, Agus H, Susilo AP. · · 2019 · cited 6× · PMID 31341830 · DOI 10.5812/aapm.91275

Verify or expand the search:

Other trials of Bupivacaine

Trials testing the same drug.

NCT05785377 — Neostigmine as an Adjuvant in Tranversus Abdominis Plane (TAP) Block in Cesarean Section Under Spinal Anesthesia · NA · not yet recruiting
NCT07467356 — Anterior Iliopsoas Space Block Versus PENG Block on Ease of Positioning for Spinal Anathesia in Patients Undergoing Hip · Phase 3 · recruiting
NCT07465185 — Intrathecal Bupivacaine With or Without Dexmetomidine for Cesserian Delivery · Phase 2 · recruiting
NCT07430085 — Post-Operative Pain Relief: Zynrelef or Periarticular Injections in RATKA · Phase 4 · not yet recruiting
NCT07146685 — Effect of Local Anesthetic Concentration on Rebound Pain: A Randomized Control Study · Phase 4 · not yet recruiting

Other recruiting trials for Cesarean Section

Currently open trials in the same condition.

NCT07511491 — Ondansetron Lozenge Versus Intravenous for Prevention of Shivering in Cesarean Section · NA · recruiting
NCT06282952 — Health Outcomes in C-Section Infants With Fecal Microbiota Transplantation · NA · recruiting
NCT07499947 — Predicting Spinal Hypotension in Cesarean Section · recruiting
NCT07413185 — Relationship Between the Severity of Sleep Deprivation in the First 48 Hours Postpartum, Breastfeeding Motivation, and B · recruiting
NCT07440667 — Restrictive vs Liberal Intraoperative Fluid Strategy and Postoperative Outcomes After Elective Cesarean Section · NA · recruiting

Other Indonesia University trials

Trials by the same sponsor.

NCT07137130 — Secretome TGF Beta 3 · NA · not yet recruiting
NCT07420335 — Preoperative Shoulder Exercises and Postoperative Inflammation, Pain, and Function After Modified Radical Mastectomy · NA · not yet recruiting
NCT07278284 — The Effectiveness of Press Needle Acupuncture on Preoperative Anxiety in Tympanoplasty and Mastoidectomy · NA · recruiting
NCT07337187 — Effect of Thread-Embedding Acupuncture at EX-B2 on Pain and Quality of Life in Chronic Low Back Pain · NA · not yet recruiting
NCT07242001 — Laser Acupuncture for Otitis Media With Effusion in Children · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03834454 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Indonesia University
Last refreshed: 11 February 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03834454.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing